Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Messa

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromesDaniela Cilloni, Enrico Gottardi, Francesca Messa, et al.
Blood|December 8, 2009
FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cellsFrancesca Pellicano, Daniela Cilloni, G Vignir Helgason, et al.
Cancer|August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubationDaniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Cancer|January 31, 2006
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cellsAlessandro Morotti, Daniela Cilloni, Francesca Messa, et al.
Haematologica|June 11, 2010
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavengingEmanuela Messa, Sonia Carturan, Chiara Maffè, et al.
Haematologica|June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working PartyIlaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
Haematologica|August 2, 2007
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective studyMichele Baccarani, Daniela Cilloni, Michela Rondoni, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromesDaniela Cilloni, Enrico Gottardi, Francesca Messa, et al.
Blood|December 8, 2009
FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cellsFrancesca Pellicano, Daniela Cilloni, G Vignir Helgason, et al.
Cancer|August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubationDaniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Cancer|January 31, 2006
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cellsAlessandro Morotti, Daniela Cilloni, Francesca Messa, et al.
Haematologica|June 11, 2010
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavengingEmanuela Messa, Sonia Carturan, Chiara Maffè, et al.
Haematologica|June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working PartyIlaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
Haematologica|August 2, 2007
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective studyMichele Baccarani, Daniela Cilloni, Michela Rondoni, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Pageof 3